Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cerebral small vessel disease-related brain lesions such as white matter lesions and lacunes are common findings of magnetic resonance imaging in the elderly. These lesions are thought to be major contributors to disability in old age, and risk factors that include age and hypertension have been established. The radiological, histopathologic and clinical phenotypes of age-related cerebral small vessel disease remarkably resemble autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy, which is caused by mutations in NOTCH3. We hypothesized that genetic variations in NOTCH3 also play a role in age-related cerebral small vessel disease. We directly sequenced all 33 exons, the promoter and 3'-untranslated region of NOTCH3 in 195 participants with either coalescent white matter lesions or lacunes and compared the results to 82 randomly selected participants with no focal changes on magnetic resonance images in the Austrian Stroke Prevention Study. We detected nine common and 33 rare single nucleotide polymorphisms, of which 20 were novel. All common single nucleotide polymorphisms were genotyped in the entire cohort (n = 888), and four of them, rs1043994, rs10404382, rs10423702 and rs1043997, were associated significantly with both the presence and progression of white matter lesions. The association was confined to hypertensives, a result which we replicated in the Cohorts for Heart and Ageing Research in Genomic Epidemiology Consortium on an independent sample of 4773 stroke-free hypertensive elderly individuals of European descent (P = 0.04). The 33 rare single nucleotide polymorphisms were scattered over the NOTCH3 gene with three being located in the promoter region, 24 in exons (18 non-synonymous), three in introns and three in the 3'-untranslated region. None of the single nucleotide polymorphisms affected a cysteine residue. Sorting Intolerant From Tolerant, PolyPhen2 analyses and protein structure simulation consistently predicted six of the non-synonymous single nucleotide polymorphisms (H170R, P496L, V1183M, L1518M, D1823N and V1952M) to be functional, with four being exclusively or mainly detected in subjects with severe white matter lesions. In four individuals with rare non-synonymous single nucleotide polymorphisms, we noted anterior temporal lobe hyperintensity, hyperintensity in the external capsule, lacunar infarcts or subcortical lacunar lesions. None of the observed abnormalities were specific to cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. This is the first comprehensive study investigating (i) the frequency of NOTCH3 variations in community-dwelling elderly and (ii) their effect on cerebral small vessel disease related magnetic resonance imaging phenotypes. We show that the NOTCH3 gene is highly variable with both common and rare single nucleotide polymorphisms spreading across the gene, and that common variants at the NOTCH3 gene increase the risk of age-related white matter lesions in hypertensives. Additional investigations are required to explore the biological mechanisms underlying the observed association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the identification of MRI differences between CADASIL patients and non-carriers, these differences are overall limited and not consistently found across studies.”
From Clinical and research applications of magnetic resonance imaging in the study of CADASIL (2019) · cites this paper as [63]
In the citing paper
“MRI features described as specific to CADASIL, including temporal pole WMH, have been observed in a considerable proportion of subjects without NOTCH3 mutations, limiting their specificity [51, 58, 63].”
From Clinical and research applications of magnetic resonance imaging in the study of CADASIL (2019) · cites this paper as [63]
In the citing paper
“In terms of other common vascular risk factors, concurrent smoking also appears to be a key risk factor for WMH and their progression,97 whereas statins did not prevent WMH progression.12”
From Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging (2013) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Research works printed but not linked: 1
- 1998, Annals of neurology, 44, 31
Cited by
Items 101–131 of 131
Impact of Arterial Aging on Early and Late Stages of Brain Damage
Scuteri, A., & Debette, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00019-3 · Cited by 1
Self-citationGenetics of Small Vessel Disease
Malik, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-56210-0_14 · Cited by 1
Wang, P., Yao, M., Yuan, J., Han, F., Zhai, F., Zhang, D., Zhou, L., Ni, J., Zhang, S., Cui, L., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032668 · Cited by 1
Sam, K. (2016) · TSpace (University of Toronto) · Cited by 1
Jiménez-Baladó, J., & Molecular, U. A. D. B. D. D. B. I. D. B. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Illarioshkin, S. N., Абрамычева, Н. Ю., Калашникова, Л. А., Максимова, М. Ю., Коновалов, Р. Н., Stepanova, M., & Fedotova, E. Y. (2013) · The Neurological Journal
Understanding brain function through small vessel disease: What zebras can teach us about horses
Seshadri, S. S., & de Leeuw, F. (2014) · Neurology · doi:10.1212/wnl.0000000000000484
Genetic associations with sporadic cerebral small vessel disease
Rannikmäe, K. (2017) · ERA
Genetics of Cerebral Small Vessel Disease
Tan, Y. Y. R. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.30570
The Impact of Aging and Age-Related Comorbidities on Stroke Outcome in Animal Models and Humans
Popa‐Wagner, A., Popescu-Drigă, M. V., & Glăvan, D. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-54564-2_12
Autopsy confirmed CADASIL with the c.1490C > T (p.S497L) variant of uncertain causal significance
Táborský, J., Matěj, R., Vlášková, H., Keller, J., Johanidesová, S., & Rusina, R. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05883-6
Arterial Aging, Blood Pressure, and Brain Damage
Scuteri, A., Debette, S., & Avolio, A. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00030-1
Self-citationGiese, A., & Rost, N. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-41777-1_12
Genetics of Small Vessel Disease
Marini, S., Parodi, L., Malik, R., & Anderson, C. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-41777-1_13
Hussein, F. S., Sayed, S. S. E., Mohammed, H. S., & Kamal, M. M. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00641-7
Case Report: Decoding genetic risks of vascular parkinsonism: a case series
Shalash, A., El-Shafie, S., George, P., Roushdy, T. M. E. S., Fathy, M., Yousef, M. H., El-Belkimy, M., Abdulghani, M. O., & Salama, M. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1579454
Protein Repair Strategies for the Functional Restoration of CARASIL-relevant HTRA1 Mutants
Ingendahl, L. (2023) · DuEPublico (University of Duisburg-Essen) · doi:10.17185/duepublico/47773
The Genetic Landscape of Neurodegenerative and Cerebrovascular Disease Phenotypes.
Dilliott, A. A. (2021) · Scholarship@Western (Western University)
Lindemer, E. (2017) · DSpace@MIT (Massachusetts Institute of Technology)
Lésions de la substance blanche dans la maladie CADASIL
Cognat, E. (2016) · theses.fr (ABES) · doi:10.70675/1eee22c3za11bz453cz98fez8bffddebcfff
Genetic determinants of MRI-markers of vascular brain aging
Saba, Y. (2024) · theses.fr (ABES) · doi:10.70675/a531351bz0a42z449az85bez3b69b1a65670
Investigating Heritable Stroke Genes in Migraine and Migraine Related Disorders
Molaee, Z. (2026) · Queensland University of Technology · doi:10.5204/thesis.eprints.265767
Guyler, S. K. (2026) · Queensland University of Technology · doi:10.5204/thesis.eprints.266336
Psychiatric Comorbidities of Neurogenetic and Neurodegenerative Diseases
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8487-3
Paolucci, M., Urbinati, G., Migliaccio, L., Marucci, A., Favoni, V., Mascarella, D., Palombo, F., Carelli, V., Sebastiani, M., Stagni, S., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1952744
Avaliação de potenciais marcadores de diagnóstico e prognóstico em doentes CADASIL
Elias, I. C. D. F. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Supporting information 2 of Genetic Study of Cerebral Small Vessel Disease in Chinese Han Population
Yunchao Wang, Shi, C., Li, Y., Wenkai Yu, Sen Wei, Yu Fan, Chengyuan Mao, Zhihua Yang, Lulu Yu, Zichen Zhao, et al. (2022) · doi:10.3389/fneur.2022.829438.s002
Metadata
- Authors
- Schmidt, H., Zeginigg, M., Wiltgen, M., Freudenberger, P., Petrovic, K., Cavalieri, M., Gider, P., Enzinger, C., Fornage, M., Debette, S., Rotter, J. I., Ikram, M. A., Launer, L. J., Schmidt, R., & on behalf of the CHARGE consortium Neurology working group
- Affiliations
- Medical University of Graz (AT)
- Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
- Boston University (US)
- Cedars-Sinai Medical Center (US)
- Erasmus MC (NL)
- National Institutes of Health (US)
- Corresponding author
- Schmidt, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-17
- Volume
- 134
- Issue
- 11
- Pages
- 3384-3397
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3212720
- OpenAlex
- W2076428954
- Cited by
- 112
- References
- 60
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 12 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 4 · 2015: 17 · 2014: 11 · 2013: 7 · 2012: 5
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- School of Medicine, Boston University
- Cedars-Sinai Medical Center
- European Commission
- ZonMw (050-060-810)
- Austrian Science Fund (P20545)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (050.060.810, 175.010.2005.011)
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- Hjartavernd (N01-AG-1-2100)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc045133-001, n01ag12100-57-0-2, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01hc55021-47-0-1, n01hc085085-011, n01hc085083-027, n01hc55020-39-0-0, n01hc085080-026, n01hc55016-37-0-0, n01hc055022-024, n01hc085086-022, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc25195-41-0-1, n01hc55222-0-0-0, HHSN268200625226C, n01hc075150-004, n01hc035129-010, n01hc55015-48-0-1)
- U.S. Public Health Service (HHSN 268200625226C)
- National Institute on Aging (N01-HC-55021, AG-16495, N01HC85079, N01 HC‐15103, N01-AG12100, N01-AG012100, N02-HL-6-4278, N01HC55222, N01‐HC‐35129, R01AG031287, N01-HC-75150, AG031287, AG08122, N01-HC-55018, AG033193, R01AG016495, HL080295, N01‐HC‐45133, N01-HC-55015, N01‐HC‐85086, N01-HC-55019, N01-HC-55020, N01-HC-55016, R01AG033193, R01AG008122, N01-HC-55022)
- National Heart, Lung, and Blood Institute (N01-HC-85081, DK-063491, N01HC85085, N01-HC55022, N01 HC085086, HC-55016, N01HC-85083, N01 HC055016, N01-HC-55018, HC-85086, HC25195, N01HC15103, N01 HC 55020, N01 HC085079, HC85079, N01‐HC25195, HC-55021, HL-087652, HC-55018, N01 HC 55019, N01HC85082, N01HC‐75150, AG08122, N01 HC85086, R01HL087652, HC-55022, N01 HC055020, N01HC85080, AG031287, HC-55019, N01-HC, HC-35129, N02- HL-64278, N01 HC055018, N01 HC55222, HL-093029, HC-55015, HC-45133, HHSN268200625226C, N01‐HC‐45133, HC-55020, N01-HC-025195, N01-HC55016, R01HL087641, N01 HC055022, R01HL093029, U01HL080295, N01 HC055019, AG16495, HL087641, AG033193, HL080295, N01‐HC‐55015, N01-HC55021, N01 HC075150, N01 HC055021, HC-15103, N01 HC055015, N01-HC85079, N01-HC85084, N01HC35129)
- National Human Genome Research Institute (U01HG004402)
- National Eye Institute
- National Institute on Deafness and Other Communication Disorders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, N01-HC-55016, N01-HC-55018, N01-HC-55021, N01-HC-55020, N01-HC-55015, N01-HC-55019, N01-HC-55022, P30DK063491)
- National Institute of Neurological Disorders and Stroke (NS17950, R01NS017950)
- National Center for Research Resources (UL1RR025005, M01RR000425, M01-RR00425)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- NOTCH3 gene, cerebral small vessel disease, white matter lesions, lacunes, single nucleotide polymorphisms, rare variants, hypertension, genetic susceptibility, novel variants, variant effect prediction, older adults, stroke prevention, CHARGE consortium
- MeSH terms
- Receptor, Notch3, Aged, Aged, 80 and over, Alleles, Brain, Exons, Female, Follow-Up Studies, Genotype, Humans, Hypertension, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Promoter Regions, Genetic, Prospective Studies, Receptors, Notch, Genetic Association Studies, Cerebral Small Vessel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.